Literature DB >> 28347755

Inhibition of inflammation induced shedding of the endothelial glycocalyx with low molecular weight heparin.

Herbert H Lipowsky1, Anne Lescanic2.   

Abstract

The endothelial surface layer (ESL) consists of the endothelial cell (EC) glycocalyx and adsorbed proteins, and forms a barrier between blood and the EC. Enzymatic shedding of the ESL in response to cytokines may expose receptors for leukocyte (WBC) adhesion and increase vascular permeability. Thus, intravital microscopy was used to explore stabilization of the ESL with low molecular weight heparin (LMWH) to mitigate structural changes with inflammation. Following bolus infusions (i.v.) of LMWH (0.12-1.6mg/kg), shedding of glycans in response to 10-7M fMLP was measured by loss of fluorescently labeled lectins bound to the EC and WBC-EC adhesion was monitored in post-capillary venules of rat mesentery. During a 30min exposure to fMLP, a 50% reduction in fluorescence (indicative of glycan shedding) occurred at the lowest dose of LMWH whereas a 50% increase occurred (indicative of ESL compaction) at the highest dose. Shedding was reduced by LMWH in a dose dependent manner with an EC50 of 0.6mg/kg. Concomitant WBC-EC adhesion increased over 3-fold for all doses of LMWH. However, at a dose of 1.6mg/kg, WBC-EC adhesion did not rise significantly during the initial 10min exposure to fMLP. Correlation of WBC adhesion with intensity of the lectin stain for all measurements revealed a significant 40% reduction in adhesion as intensity increased 50%. This relationship was attributed to LMWH inhibition of heparanase and/or binding to components of the glycocalyx that resulted in mitigation of glycan shedding, compaction of the lectin stain and stabilization of the glycocalyx.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Endothelium; Glycocalyx; Heparin; Inflammation; Mesentery; Venules

Mesh:

Substances:

Year:  2017        PMID: 28347755      PMCID: PMC5510244          DOI: 10.1016/j.mvr.2017.03.007

Source DB:  PubMed          Journal:  Microvasc Res        ISSN: 0026-2862            Impact factor:   3.514


  65 in total

Review 1.  Cell surface heparan sulfate proteoglycans: selective regulators of ligand-receptor encounters.

Authors:  P W Park; O Reizes; M Bernfield
Journal:  J Biol Chem       Date:  2000-09-29       Impact factor: 5.157

2.  Low molecular weight heparin inhibits tumor necrosis factor alpha-induced leukocyte rolling.

Authors:  M X Wan; X W Zhang; L Törkvist; H Thorlacius
Journal:  Inflamm Res       Date:  2001-12       Impact factor: 4.575

3.  Effect of unfractionated heparin on endothelial glycocalyx in a septic shock model.

Authors:  S Yini; Z Heng; A Xin; M Xiaochun
Journal:  Acta Anaesthesiol Scand       Date:  2014-10-14       Impact factor: 2.105

4.  Shedding of the endothelial glycocalyx in arterioles, capillaries, and venules and its effect on capillary hemodynamics during inflammation.

Authors:  Herbert H Lipowsky; Lujia Gao; Ann Lescanic
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-09-16       Impact factor: 4.733

5.  The response of human neutrophils to a chemotactic tripeptide (N-formyl-methionyl-leucyl-phenylalanine) studied by microcinematography.

Authors:  J Maher; J V Martell; B A Brantley; E B Cox; J E Niedel; W F Rosse
Journal:  Blood       Date:  1984-07       Impact factor: 22.113

Review 6.  Heparan sulphate as a regulator of leukocyte recruitment in inflammation.

Authors:  Archana V Kumar; Sampath K Katakam; Ann-Kathrin Urbanowitz; Martin Gotte
Journal:  Curr Protein Pept Sci       Date:  2015       Impact factor: 3.272

7.  Inhibition of selectin-mediated cell adhesion and prevention of acute inflammation by nonanticoagulant sulfated saccharides. Studies with carboxyl-reduced and sulfated heparin and with trestatin a sulfate.

Authors:  X Xie; A S Rivier; A Zakrzewicz; M Bernimoulin; X L Zeng; H P Wessel; M Schapira; O Spertini
Journal:  J Biol Chem       Date:  2000-11-03       Impact factor: 5.157

Review 8.  Degradation of the endothelial glycocalyx in clinical settings: searching for the sheddases.

Authors:  Bernhard F Becker; Matthias Jacob; Stephanie Leipert; Andrew H J Salmon; Daniel Chappell
Journal:  Br J Clin Pharmacol       Date:  2015-05-22       Impact factor: 4.335

9.  Shedding of the endothelial glycocalyx in patients undergoing major vascular surgery with global and regional ischemia.

Authors:  Markus Rehm; Dirk Bruegger; Frank Christ; Peter Conzen; Manfred Thiel; Matthias Jacob; Daniel Chappell; Mechthild Stoeckelhuber; Ulrich Welsch; Bruno Reichart; Klaus Peter; Bernhard F Becker
Journal:  Circulation       Date:  2007-10-08       Impact factor: 29.690

10.  Inhibition of heparanase-mediated degradation of extracellular matrix heparan sulfate by non-anticoagulant heparin species.

Authors:  M Bar-Ner; A Eldor; L Wasserman; Y Matzner; I R Cohen; Z Fuks; I Vlodavsky
Journal:  Blood       Date:  1987-08       Impact factor: 22.113

View more
  14 in total

Review 1.  Endothelial barrier reinforcement relies on flow-regulated glycocalyx, a potential therapeutic target.

Authors:  Ian C Harding; Ronodeep Mitra; Solomon A Mensah; Alina Nersesyan; Nandita N Bal; Eno E Ebong
Journal:  Biorheology       Date:  2019       Impact factor: 1.875

Review 2.  Management of postoperative microvascular compromise and ischemia reperfusion injury in breast reconstruction using autologous tissue transfer: Retrospective review of 2103 flaps.

Authors:  Michelle Coriddi; Paige Myers; Babak Mehrara; Jonas Nelson; Peter G Cordeiro; Joseph Disa; Evan Matros; Joseph Dayan; Robert Allen; Colleen McCarthy
Journal:  Microsurgery       Date:  2021-12-02       Impact factor: 2.425

Review 3.  Biomarkers in Cardiorenal Syndrome and Potential Insights Into Novel Therapeutics.

Authors:  Edmund Y M Chung; Katie Trinh; Jennifer Li; Sebastian Hayden Hahn; Zoltan H Endre; Natasha M Rogers; Stephen I Alexander
Journal:  Front Cardiovasc Med       Date:  2022-05-20

Review 4.  The Endothelial Glycocalyx: A Possible Therapeutic Target in Cardiovascular Disorders.

Authors:  Anastasia Milusev; Robert Rieben; Nicoletta Sorvillo
Journal:  Front Cardiovasc Med       Date:  2022-05-13

Review 5.  Regulation of Chemokine Function: The Roles of GAG-Binding and Post-Translational Nitration.

Authors:  Sarah Thompson; Beatriz Martínez-Burgo; Krishna Mohan Sepuru; Krishna Rajarathnam; John A Kirby; Neil S Sheerin; Simi Ali
Journal:  Int J Mol Sci       Date:  2017-08-03       Impact factor: 5.923

Review 6.  Heparin and Its Derivatives: Challenges and Advances in Therapeutic Biomolecules.

Authors:  Nipa Banik; Seong-Bin Yang; Tae-Bong Kang; Ji-Hong Lim; Jooho Park
Journal:  Int J Mol Sci       Date:  2021-09-29       Impact factor: 5.923

Review 7.  Vascular Endothelial Cell Biology: An Update.

Authors:  Anne Krüger-Genge; Anna Blocki; Ralf-Peter Franke; Friedrich Jung
Journal:  Int J Mol Sci       Date:  2019-09-07       Impact factor: 5.923

Review 8.  Endothelial cells, neutrophils and platelets: getting to the bottom of an inflammatory triangle.

Authors:  Tima Dehghani; Alyssa Panitch
Journal:  Open Biol       Date:  2020-10-14       Impact factor: 6.411

9.  SARS-CoV-2: What is known and what there is to know-Focus on coagulation and lipids.

Authors:  Federico Carbone; Fabrizio Montecucco; Marcel Twickler
Journal:  Eur J Clin Invest       Date:  2020-06-25       Impact factor: 5.722

Review 10.  Endothelial glycocalyx in traumatic brain injury associated coagulopathy: potential mechanisms and impact.

Authors:  Zhimin Zou; Li Li; Nadine Schäfer; Qiaobing Huang; Marc Maegele; Zhengtao Gu
Journal:  J Neuroinflammation       Date:  2021-06-14       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.